ARCHIVES

Pediatric Oncology Groups Plan To Merge, Citing Greater Cost Efficiencies, Leverage

This article is from The Cancer Letter archive.

Vol. 24 No. 31 | August 7, 1998

Download PDF Visit The Full Archive

Related Articles

Cancer Control Contractors Severally Criticized In Merit Peer Review; Inadequate Reports Cited

May 28, 1976

Arnold Levine Named Professor At UMDNJ

February 28, 2003

Raub Corrects Record on ALERT

April 20, 1984

Hood’s ISB Gets $5 Million From Merck, Hires Scientists.

September 1, 2000

NIH Objects To Big Response On Immunology RFPs, But NCI Will Continue Wide Distribution

November 1, 1974

Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer

July 26, 2002